Szilvia Török
- Pharmacology top 10%
- Apelin-related biomedical research 3
-
- Adipose Tissue and Metabolism 3
-
- Mass Spectrometry Techniques and Applications 4
-
- Heme Oxygenase-1 and Carbon Monoxide 4
-
- Lung Cancer Treatments and Mutations 3
-
- Regulation of Appetite and Obesity 3
-
- Vitamin C and Antioxidants Research 3
-
- Sulfur Compounds in Biology 3
Szilvia Török
43 papers receiving 904 citations
Peers
Comparison fields: 5 of 114
- Biological Psychiatry 19
- Endocrinology, Diabetes and Metabolism 111
- Pharmacology 109
- Drug Discovery 1
- Physiology 125
Countries citing papers authored by Szilvia Török
This map shows the geographic impact of Szilvia Török's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Szilvia Török with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Szilvia Török more than expected).
Fields of papers citing papers by Szilvia Török
This network shows the impact of papers produced by Szilvia Török. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Szilvia Török. The network helps show where Szilvia Török may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Szilvia Török, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2024 | 3 | |
| 3 | 2023 | 4 | |
| 4 | 2023 | 2 | |
| 5 | 2023 | 12 | |
| 6 | 2023 | 7 | |
| 7 | 2021 | 23 | |
| 8 | 2018 | 18 | |
| 9 | 2018 | 15 | |
| 10 | 2017 | 10 | |
| 11 | 2016 | 48 | |
| 12 | 2016 | 54 | |
| 13 | 2016 | 46 | |
| 14 | 2015 | 17 | |
| 15 | Novel features of the rat model of inflammatory bowel disease based on 2,4,6-trinitrobenzenesulfonic acidinduced acute colitis | 2014 | 3 |
| 16 | 2014 | 14 | |
| 17 | 2013 | 28 | |
| 18 | 2013 | 17 | |
| 19 | 2012 | 1 | |
| 20 | [Nintedanib (BIBF 1120) in the treatment of solid cancers: an overview of biological and clinical aspects]. | 2012 | 2 |
About Szilvia Török
Szilvia Török is a scholar working on Endocrine and Autonomic Systems, Biochemistry and Biological Psychiatry, having authored 43 papers that have together received 917 indexed citations. Recurring topics across this work include Mass Spectrometry Techniques and Applications (4 papers), Heme Oxygenase-1 and Carbon Monoxide (4 papers), Lung Cancer Treatments and Mutations (3 papers), Apelin-related biomedical research (3 papers), Adipose Tissue and Metabolism (3 papers), Regulation of Appetite and Obesity (3 papers), Vitamin C and Antioxidants Research (3 papers) and Sulfur Compounds in Biology (3 papers). The work is most often cited by research in Biological Psychiatry (19 citations), Endocrinology, Diabetes and Metabolism (111 citations) and Pharmacology (109 citations). Szilvia Török has collaborated with scholars based in Hungary, Austria and Sweden. Frequent co-authors include Csaba Varga, Krisztina Kupai, Anikó Pósa, Balázs Döme, Médea Veszelka, Zsolt Murlasits, Amin Al-Awar, Gergő Szűcs, Balázs Hegedűs and Zouhair K. Attieh. Their work appears in journals such as PLoS ONE, Scientific Reports and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.